Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three ...
16h
Pacira BioSciences: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...
About Pacira Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three ...
I write about money. I’ve been reviewing tax software and services as a freelancer for PCMag since 1993. Along the way, I took on reviews of other types of business and personal finance technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback